^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SynKIR-110

i
Other names: SynKIR-110, autologous T cells transduced with mesothelin KIR-CAR
Company:
University of Pennsylvania, Verismo Therap
Drug class:
Mesothelin-targeted CAR-T immunotherapy